News

CDC accepts RSV recommendations made by former vaccine panel
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up.
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
Zacks Investment Research on MSN10d
MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
MedPage Today on MSN11d
CDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV Shot
With the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...
HealthDay on MSN2d
CDC Now Recommends RSV Vaccine for Some Adults 50+
Adults as young as 50 may now qualify for an respiratory synctial virus vaccine if they have certain health conditions.
RSV vaccine access expanded to some people in their 50s, according to CDC website
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...
BioSpace10d
Kennedy Follows RSV Recommendations of ACIP Members He Fired
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
US CDC accepts RSV recommendations made by former vaccine panel
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...
U.S. CDC accepts the former vaccine panel's RSV recommendations
The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed ...
AZ Central11d
CDC accepts RSV recommendations made by former vaccine panel
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the use of respiratory syncytial virus vaccines in adults aged between 50 and ...